Pulse Biosciences, Inc. (PLSE) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

Pulse Biosciences, Inc.

PLSE

NASDAQ

Unprofitable

Medical - Instruments & Supplies

Next Earning date - 05 May 2025

Medical - Instruments & Supplies

Next Earning date - 05 May 2025

17.74USD

0.85 ( 5.03%)

Market Closed (as of Apr 17, 20:00 EDT)

Relative Strenght

Volume Buzz

-34%

Earning Acce

Dist 52w H.

29%

Overview Chart

Quote Panel

Updated April 20, 2025

1W 7.26 % 1M 10.46 % 3M -9.40 % 1Y 158.98 %

Key Metrics

Market Cap
1.19B
Shares Outstanding
67.27M
Share in Float
12.56M
Dividende
0

Earning Date
05 May 2025
Price Target
17.74
Average Volume
185887
Beta
1.879

Range
6.595-25
Industry
Medical - Instruments & Supplies
Website
https://www.pulsebiosciences.com
Sector
Healthcare

Quote Panel

Updated April 20, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

0.00x

P/S Ratio

9.23x

P/B Ratio

0.1

Debt/Equity

0.0%

Net Margin

$-0.9

EPS

How PLSE compares to sector?

P/E Ratio

Fundamentals

Relative Strength

PLSE

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

PLSE

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$23M

NaN%

2025-Revenue

$0.60

-88%

2025-EPS

$5M

123%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q3.22

N/A

-0.46
vs -0.42

Q4.22

N/A

-0.22
vs -0.39

Q1.23

N/A

-0.23
vs -0.58

Q2.23

N/A

-0.19
vs -0.37

Q3.23

N/A

-0.15
vs -0.46

Q4.23

N/A

-0.15
vs -0.22

Q1.24

N/A

-0.14
vs -0.23

Q2.24

N/A

-0.21
vs -0.19

Q3.24

N/A

-0.16
vs -0.15

Q4.24

N/A

-0.17
vs -0.15

Sales Growth

YoY

Current

Estimates

Q3.22

-100%

NA vs 574K

Q4.22

-101%

-9000.00 vs 844K

Q1.23

-100%

NA vs 444K

Q2.23

-100%

NA vs 265K

Q3.23

NA vs NA

Q4.23

+19433%

1.7M vs -9000

Q1.24

NA vs NA

Q2.24

NA vs NA

Q3.24

NA vs NA

Q4.24

-100%

NA vs 1.7M

Return on Equity

QoQ

Q1.23

+96%

0.96
vs 4.08

Q2.23

-16%

-0.16
vs 0.96

Q3.23

-20%

-0.20
vs -0.16

Q4.23

-27%

-0.27
vs -0.20

Q1.24

-28%

-0.28
vs -0.27

Q2.24

-42%

-0.42
vs -0.28

Q3.24

-16%

-0.16
vs -0.42

Q4.24

-17%

-0.17
vs -0.16

Institutionnal Ownership

QoQ

Q1.23

29
vs 31

-6%

Q2.23

46
vs 29

59%

Q3.23

46
vs 46

Q4.23

56
vs 46

22%

Q1.24

67
vs 56

20%

Q2.24

60
vs 67

-10%

Q3.24

75
vs 60

25%

Q4.24

74
vs 75

-1%

Earnings Growth

Latest News

businesswire.com

8 hours ago

Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025

businesswire.com

8 hours ago

Pulse Biosciences' Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting

businesswire.com

16 hours ago

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

businesswire.com

16 hours ago

Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference

businesswire.com

16 hours ago

Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference

seekingalpha.com

19 hours ago

Pulse Biosciences, Inc. (PLSE) Q4 2024 Earnings Call Transcript

Company Description

17.74USD

N/A

0.00x

9.23x

0.1

0.0%

$-0.9

$23M

$0.60

$5M

Earnings Growth

Latest News

$23M

$0.60

$5M

Company Description

17.74USD

N/A

0.00x

9.23x

0.1

0.0%

$-0.9